Healthcare Management Alkermes Receives Fda Fast Track Designation For Nemvaleukin Alfa In Combination With Pembrolizumab… AIT News Desk Oct 26, 2021 - Second Fast Track Designation for Nemvaleukin - Alkermes plc announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track…
Healthcare Management Leucid Bio Raises £11.5Million In Series A Financing To Develop Next Generation Of Innovative… AIT News Desk Oct 21, 2021 Leucid Bio a biotech company pioneering next-generation cell therapies for hard-to-treat cancers, today announces that it has successfully raised…